PRCT Q3 2022 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M+134.8% YoY

Gross Profit

$10M50.3% margin

Operating Income

-$22M-108.6% margin

Net Income

-$23M-111.1% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+21.9%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$324M

Total Liabilities

$103M

Stockholders' Equity

$221M

Cash & Equivalents

$249M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$9M	+134.8%
Gross Profit	$10M	$4M	+141.3%
Operating Income	-$22M	-$13M	-72.7%
Net Income	-$23M	-$14M	-60.3%

Geographic Segments

UNITED STATES

$10M93%

Outside the United States

$743,0007%